Global Autoimmune Disease Drugs Market Growth 2025-2031

The global Autoimmune Disease Drugs market size is predicted to grow from US$ 144220 million in 2025 to US$ 179700 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.

Autoimmune Disease Drugs refer to a class of drugs used to treat autoimmune diseases that are caused by the immune system mistakenly attacking the body's own tissues. These drugs are designed to regulate or suppress an overactive immune response to reduce symptoms, slow disease progression, and help patients maintain a normal quality of life. Common autoimmune disease drugs include anti-inflammatory drugs, immunosuppressants, biologics, etc., which act on the immune system through different mechanisms to control the condition and reduce damage to the body.

United States market for Autoimmune Disease Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Autoimmune Disease Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Autoimmune Disease Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Autoimmune Disease Drugs players cover Qyuns Therapeutics, Bio-Thera Solutions, Hengrui Pharmaceuticals, Hisun Pharmaceutical, Sunshine Guojian Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Autoimmune Disease Drugs Industry Forecast” looks at past sales and reviews total world Autoimmune Disease Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Drugs sales for 2025 through 2031. With Autoimmune Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Drugs industry.

This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmune Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disease Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Biopharma
Small Molecule Drug

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Qyuns Therapeutics
Bio-Thera Solutions
Hengrui Pharmaceuticals
Hisun Pharmaceutical
Sunshine Guojian Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Chongqing Genrix Biopharmaceutical
Keymed Biosciences
Junshi Biosciences
Akeso
AbbVie
AstraZeneca
Biogen
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Pfizer
Roche Holding
Sanofi S.A.
Takeda Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Autoimmune Disease Drugs market?

What factors are driving Autoimmune Disease Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Autoimmune Disease Drugs market opportunities vary by end market size?

How does Autoimmune Disease Drugs break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.